C-Reactive protein predicts short-term mortality in patients with cirrhosis
Authors:
- Thierry ThévenotTTThierry Thévenot
- Delphine WeilDWDelphine Weil
- Emilie MuelEMEmilie Muel
- Olivier BarbotOBOlivier Barbot
- Frances SheppardFSFrances Sheppard
- Elisabeth MonnetEMElisabeth Monnet
- Vincent Di MartinoVMVincent Di Martino
- 1 June 2012
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 56 (6) , 1299-1304
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Is this really the end of beta-blockers in patients with cirrhosis and refractory ascites?Hepatology, 2010
- Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality†‡§Hepatology, 2009
- Associations of Circulating C-Reactive Protein and Interleukin-6 with Survival in Women with and without Cancer: Findings from the British Women's Heart and Health StudyCancer Epidemiology, Biomarkers & Prevention, 2007
- Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitisHepatology, 2006
- Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosisDiagnostic Microbiology and Infectious Disease, 2005
- Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangementHepatology, 2003
- Bacterial translocation of enteric organisms in patients with cirrhosisJournal of Hepatology, 2001
- The systemic inflammatory response syndrome in acute liver failureHepatology, 2000
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992